Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Andrea L. Buras"'
Publikováno v:
Case Reports in Surgery, Vol 2022 (2022)
Oxidized regenerated cellulose (ORC) is an absorbable hemostat commonly used during gynecologic surgery. We present a case in which ORC was used in a patient undergoing posterior pelvic exenteration with ureteroneocystostomy for excision of a maligna
Externí odkaz:
https://doaj.org/article/ca86852facef4fa9a5e01a4638fbd32d
Autor:
Andrea L. Buras, Jing Yi Chern, Hye Sook Chon, Mian M. Shahzad, Robert M. Wenham, Mitchel S. Hoffman
Publikováno v:
Gynecologic Oncology Reports, Vol 37, Iss , Pp 100815- (2021)
Objective: Vascular injury during major gynecologic cancer surgery is a rare but potentially fatal complication. The purpose of this study was to review our experience with major vascular injury during gynecologic cancer surgery. Methods: This was a
Externí odkaz:
https://doaj.org/article/944518f5886a4358a224672a65684c62
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100754- (2021)
Stage IIIC is the most common stage of locally advanced sub-stage of endometrial cancer, nevertheless, the optimal management for these patients remains controversial. Adjuvant chemotherapy alone more effectively suppressed distant metastases but res
Externí odkaz:
https://doaj.org/article/4ce00757bcef4ffe83de019d047c377b
Publikováno v:
Gynecologic Oncology Reports, Vol 12, Iss C, Pp 7-8 (2015)
Externí odkaz:
https://doaj.org/article/bd9f1c8082374e9bbd65731cdb1280df
Publikováno v:
Journal of Gynecologic Surgery. 38:72-74
In this case, we discuss emergent small bowel resection and reanastomosis for a closed loop small bowel obstruction in the setting of recent bevacizumab exposure. Bevacizumab is a humanized monoclo...
Publikováno v:
Journal of Gynecologic Surgery. 37:200-204
Vascular injury is a rare but potentially fatal complication of gynecologic surgery. Reported risk factors for vascular injury during abdominal surgery include obesity, adhesions, vascular aberrati...
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2489-2495 (2021)
Cancer Medicine
Cancer Medicine
Background Increasing evidence, including multiple putative inflammatory risk factors (e.g., c‐reactive protein, and adiposity), supports that inflammation plays an important role in ovarian carcinogenesis. Resistance training (RT) is associated wi
Autor:
Carmen M. Anadon, Shelley S. Tworoger, Alexander R. A. Anderson, Robert M. Wenham, Ricardo A. Chaurio, Mary K. Townsend, Paulo C. Rodriguez, Xiaoqing Yu, Naoko Sasamoto, Carlos Moran, Andrea L. Buras, Jimena Trillo-Tinoco, Tara Lee Costich, Jose R. Conejo-Garcia, Jessica A. Mine, Subir Biswas, Chandler Gatenbee, Kathryn L. Terry, Kristen E. Rigolizzo, Douglas Marchion, Kyle K. Payne, Gunjan Mandal, Carly M. Harro
Publikováno v:
Nature. 591:464-470
Most ovarian cancers are infiltrated by prognostically relevant activated T cells1–3, yet exhibit low response rates to immune checkpoint inhibitors4. Memory B cell and plasma cell infiltrates have previously been associated with better outcomes in
Autor:
Michael Ophir, Qianqian Ming, Gunjan Mandal, Evgenii N. Tcyganov, Carmen M. Anadon, Alfredo Perales-Puchalt, Jennifer Walrath, Michael Schmidt, Paulo C. Rodriguez, Ugur Eskiocak, Carly M. Harro, Douglas C. Marchion, Jessica A. Mine, Ricardo A. Chaurio, Juan R. Cubillos-Ruiz, Subir Biswas, Julia Tchou, Kristen E. Rigolizzo, Brooke T. Mclaughlin, Jose R. Conejo-Garcia, Jason Lajoie, Dmitry I. Gabrilovich, Andrea L. Buras, Piotr Bobrowicz, Tara Lee Costich, Vincent C. Luca, Kyle K. Payne
Publikováno v:
Science. 369:942-949
Gamma delta (γδ) T cells infiltrate most human tumors, but current immunotherapies fail to exploit their in situ major histocompatibility complex-independent tumoricidal potential. Activation of γδ T cells can be elicited by butyrophilin and buty
Autor:
Andrea L Buras, Tianyi Wang, Junmin Whiting, Mary K Townsend, Brooke L Fridley, Shelley S Tworoger
Publikováno v:
Am J Epidemiol
We examined the association of sedentary behavior with risk of ovarian cancer overall, by tumor subtype, and by participant characteristics in the Nurses’ Health Study (NHS) and Nurses’ Health Study II (NHS II). A total of 69,558 NHS participants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e564235c5ed9185460d9b9e37d56ce87
https://europepmc.org/articles/PMC9271222/
https://europepmc.org/articles/PMC9271222/